Oxford University malaria vaccine gets Ghana green light
Notable first clearance for R21/Matrix-M malaria vaccine for use in a specific country
Read More
Tag: Oxford
State-of-the-art R&D facilities to be developed in Oxford city centre
Site will include creating space for student accommodation, offices, retail outlets and restaurants
Read More
Benefits of AZ vaccine outweigh risks, says MHRA
The risk of rare blood clots is currently calculated at four people in a million who receive the vaccine
Read More
New analysis backs safety, efficacy of AZ/Oxford COVID-19 jab
The data show 100% protection against severe disease, hospitalisation and death, greater vaccine efficacy with an inter-dose interval of 12 weeks or more, and the potential for reduced asymptomatic transmission
Read More
Researchers uncover new approach for targeting p53
An alliance between industry and academia created by Cancer Research UK has discovered a new approach to targeting key cancer-linked proteins previously deemed ‘undruggable’.
Read More
Novo to stream £115m into the UK via Oxford deal
Novo Nordisk has unveiled plans to invest £115 million over 10 years into a new research centre housed by the University of Oxford, marking a major boost for UK life sciences.
Read More
£13m Oxford partnership to accelerate drug innovations
Oxford University, Oxford University Innovation (OUI), Oxford Sciences Innovation (OSI) and Evotec have formed a new public-private alliance to help progress the development of new medicines stemming from Oxford research.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
